CIK 0001835597 · <br>Emerging growth company
PepGen Inc.
Sign in to watch- Ticker
- PEPG
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 703-456-8000
- Business address
- 1 MARINA PARK DRIVE, SUITE 900, BOSTON, MA, 02210
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-11-04 | McArthur James G President and CEO | Grant or award · Stock Option (Right to Buy) | +466,095 | 466,095 | ||
| 2025-11-04 | McArthur James G President and CEO | Returned to the company · Stock Option (Right to Buy) | −275,000 | 0 | ||
| 2025-11-04 | McArthur James G President and CEO | Grant or award · Stock Option (Right to Buy) | +275,000 | 275,000 | ||
| 2025-11-04 | McArthur James G President and CEO | Returned to the company · Stock Option (Right to Buy) | −300,000 | 0 | ||
| 2025-11-04 | McArthur James G President and CEO | Grant or award · Stock Option (Right to Buy) | +300,000 | 300,000 | ||
| 2025-11-04 | Donnelly Noel Chief Financial Officer | Returned to the company · Stock Option (Right to Buy) | −203,339 | 0 | ||
| 2025-11-04 | Donnelly Noel Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +203,339 | 203,339 | ||
| 2025-11-04 | Donnelly Noel Chief Financial Officer | Returned to the company · Stock Option (Right to Buy) | −169,037 | 0 | ||
| 2025-11-04 | Donnelly Noel Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +169,037 | 169,037 | ||
| 2025-11-04 | Donnelly Noel Chief Financial Officer | Returned to the company · Stock Option (Right to Buy) | −144,000 | 0 | ||
| 2025-11-04 | Donnelly Noel Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +144,000 | 144,000 | ||
| 2025-11-04 | Donnelly Noel Chief Financial Officer | Returned to the company · Stock Option (Right to Buy) | −144,000 | 0 | ||
| 2025-11-04 | Donnelly Noel Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +144,000 | 144,000 | ||
| 2025-09-30 | Oxford Science Enterprises plc Former 10% Owner | Purchase | +200,000 | $3.20 | $640K | 4,955,388 |
| 2025-09-26 | RA CAPITAL MANAGEMENT, L.P. Director | Purchase | +9,375,000 | $3.20 | $30.0M | 18,554,273 |
| 2025-06-04 | RA CAPITAL MANAGEMENT, L.P. Director | Grant or award · Stock Option (Right to Buy) | +16,000 | 16,000 | ||
| 2025-06-04 | Mayer Howard Director | Grant or award · Stock Option (Right to Buy) | +16,000 | 16,000 | ||
| 2025-06-04 | HENSON HEIDI Director | Grant or award · Stock Option (Right to Buy) | +16,000 | 16,000 | ||
| 2025-06-04 | KEATING LAURIE Director | Grant or award · Stock Option (Right to Buy) | +16,000 | 16,000 | ||
| 2025-06-04 | Dable Habib J Director | Grant or award · Stock Option (Right to Buy) | +16,000 | 16,000 |
Page 3 of 11 · 211 trades